Decoy Therapeutics Inc (DCOY) vs Propanc Biopharma Inc (PPCB)

Decoy Therapeutics Inc and Propanc Biopharma Inc are both Biotechnology companies. Decoy Therapeutics Inc and Propanc Biopharma Inc are of similar size ($2.1M and $2.0M). Propanc Biopharma Inc trades at the lower P/E: 0.0× against 0.0×. Propanc Biopharma Inc has the higher net margin (0.00% vs −698.8%) and the lower return on invested capital (−116.6% vs 0.00%). Across the 14 metrics below, Propanc Biopharma Inc leads on 11 and Decoy Therapeutics Inc on 3.

Valuation

Metric DCOY PPCB Biotechnology median
P/E 0.02 0.00 7.88
P/S 0.79 n/m 11.47
P/B 0.38 0.06 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA 0.42 n/m 0.74
EV/Sales (2.99) n/m 10.73
Earnings yield 5,960.59% 257,474.29% (28.84%)
Free cash flow yield (637.25%) (739.21%) (23.03%)

Profitability

Metric DCOY PPCB Biotechnology median
Gross margin 10.57% — 65.16%
Operating margin (706.88%) 0.00% 0.00%
Net margin (698.79%) 0.00% 0.00%
Free cash flow margin (432.43%) 0.00% 0.00%
Return on equity (827.77%) (138.20%) (57.72%)
Return on assets (278.04%) (104.68%) (49.22%)
Return on invested capital 0.00% (116.59%) 0.00%

Growth

Metric DCOY PPCB Biotechnology median
Revenue growth (TTM) (60.49%) — 5.64%
EPS growth (last fiscal year) (85.66%) 98.81% —
Revenue growth, 5-year CAGR 12.73% — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric DCOY PPCB Biotechnology median
Debt to equity 0.00 0.05 0.00
Current ratio 1.83 2.37 4.73
Net debt to EBITDA 0.85 (0.01) 0.96

Dividend

Metric DCOY PPCB Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 — 0.00

Size

Metric DCOY PPCB Biotechnology median
Market cap 1.99m 2.14m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack